Equillium, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
EQ Nasdaq 2836 www.equilliumbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Equillium, Inc.

Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504 - Jun 10th, 2026 11:45 am
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 2nd, 2026 2:05 pm
Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1 - May 29th, 2026 9:03 am
Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis - May 20th, 2026 2:05 pm
Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights - May 13th, 2026 2:01 pm
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event - Apr 20th, 2026 2:05 pm
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists - Apr 8th, 2026 6:30 am
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights - Mar 25th, 2026 2:05 pm
Here’s What Roth Capital Thinks of Equillium (EQ) Stock - Mar 24th, 2026 3:38 pm
Equillium to Participate in the 38th Annual Roth Conference - Mar 18th, 2026 6:30 am
Equillium Announces $35 Million Financing with RA Capital Management - Mar 13th, 2026 6:00 am
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference - Feb 25th, 2026 6:30 am
Equillium Conference: EQ504 Targets Ulcerative Colitis Ahead of Mid-Year Phase 1 Start - Feb 13th, 2026 11:28 am
Equillium to Participate in Upcoming Investor Conferences - Nov 20th, 2025 2:35 pm
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update - Nov 13th, 2025 2:05 pm
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 - Oct 22nd, 2025 6:00 am
Equillium Announces Leadership and Corporate Updates - Oct 6th, 2025 2:02 pm
Trending tickers: Intel, Tilray, monday.com, Equillium and AMC - Aug 12th, 2025 2:44 am
BC-Most Active Stocks - Aug 11th, 2025 8:30 am